Claudio Saddy Rodrigues Coy
Overview
Explore the profile of Claudio Saddy Rodrigues Coy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anefalos A, Martinez C, Coy C
BMC Gastroenterol
. 2024 Jul;
24(1):236.
PMID: 39068396
No abstract available.
2.
Anefalos A, Martinez C, Coy C
BMC Gastroenterol
. 2024 Apr;
24(1):127.
PMID: 38575859
Background/aim: London Protocol (LP) and Classification allied to high-resolution manometry (HRM) technological evolution has updated and enhanced the diagnostic armamentarium in anorectal disorders. This study aims to evaluate LP reproducibility...
3.
Credidio L, Martinez C, Magro D, Carvalho R, Ayrizono M, Coy C
Arq Gastroenterol
. 2024 Mar;
61:e23131.
PMID: 38451667
Background: To evaluate the relationship between the ratio of affected lymph nodes (LNR) and clinical and anatomopathological variables in patients with rectal adenocarcinoma submitted or not to neoadjuvant chemoradiotherapy. Methods:...
4.
Imbrizi M, Magro F, Coy C
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765080
Inflammatory Bowel Diseases had their first peak in incidence in countries in North America, Europe, and Oceania and are currently experiencing a new acceleration in incidence, especially in Latin America...
5.
Gois G, Montalvao S, Anhaia T, Almeida M, Martinelli B, Fernandes M, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686683
Cancer is a leading cause of death, and the fibrinolytic system shows cooperative effects that facilitate the growth of tumors and the appearance of metastases. This prospective study aimed to...
6.
Avellaneda N, Coy C, Fillmann H, Saad-Hossne R, Munoz J, Garcia-Duperly R, et al.
Cir Esp (Engl Ed)
. 2023 May;
101(12):824-832.
PMID: 37244420
Introduction: Complications after ileocecal resection for Crohn's disease (CD) are frequent. The aim of this study was to analyze risk factors for postoperative complications after these procedures. Materials And Methods:...
7.
Baima J, Imbrizi M, Andrade A, Chebli L, Argollo M, Queiroz N, et al.
Arq Gastroenterol
. 2023 Mar;
59(suppl 1):51-84.
PMID: 36995889
Background: Inflammatory bowel diseases are immune-mediated disorders that include Crohn's disease (CD) and ulcerative colitis (UC). UC is a progressive disease that affects the colorectal mucosa causing debilitating symptoms leading...
8.
Imbrizi M, Baima J, Azevedo M, Andrade A, Queiroz N, Chebli J, et al.
Arq Gastroenterol
. 2023 Mar;
59(suppl 1):20-50.
PMID: 36995888
Background: Inflammatory bowel disease (IBD) is an immune-mediated disorder that includes Crohn's disease (CD) and ulcerative colitis. CD is characterized by a transmural intestinal involvement from the mouth to the...
9.
de Souza L, Magro D, Teixeira F, Parra R, Miranda E, Feres O, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839908
Despite some variability in ideal serum Adalimumab (ADA) concentrations, there is increasing evidence that higher concentrations of anti-TNF-α agents can be associated with sustained efficacy, and low or undetectable levels...
10.
Fratta C, Pinheiro L, Costa F, Magro D, Martinez C, Coy C
Arq Gastroenterol
. 2022 Sep;
59(3):334-339.
PMID: 36102428
Background: The treatment of distal rectal cancer may be accompanied by evacuation disorders of multifactorial etiology. Neoadjuvant chemoradiotherapy (NCRT) is part of the standard treatment for patients with locally advanced...